Exosomes and Exosomal MiRNAs: A New Avenue for the Future Treatment of Rheumatoid Arthritis

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Mar 27

PMID 38533025

Authors

Yuan Liu

Ping Jiang

Yuan Qu

Chuanguo Liu

Di Zhang

Bing Xu

Qian Zhang

Affiliations

Soon will be listed here.

Abstract

Rheumatoid arthritis is a chronic systemic autoimmune disease that involves mainly synovitis and joint injury and is one of the main causes of disability. The pathogenesis of rheumatoid arthritis is complicated, and the treatment cycle is long. The traditional methods of inhibiting inflammation and immunosuppression are no longer sufficient for treatment of the disease, so there is an urgent need to seek new treatments. The exocrine microenvironment is a kind of microvesicle with a lipid bilayer membrane structure that can be secreted by most cells in the body. This structure contains cell-specific proteins, lipids and nucleic acids that can transmit this information from one cell to another. To achieve cell-to-cell communication. Exocrine microRNAs can be contained in exocrine cells and can be selectively transferred to target receptor cells via exocrine signaling, thus regulating the physiological function of target cells. This article focuses on the pathological changes that occur during the development of rheumatoid arthritis and the biological regulation of exocrine and exocrine microRNAs in rheumatoid joints. Research on the roles of exocrine and exocrine microRNAs in regulating the inflammatory response, cell proliferation/apoptosis, autophagy, effects on fibroblast-like synoviocytes and immune regulation in rheumatoid arthritis was reviewed. In addition, the challenges faced by this new treatment are discussed.

References

Tanaka S, Tanaka Y . RANKL as a therapeutic target of rheumatoid arthritis. J Bone Miner Metab. 2020; 39(1):106-112. DOI: 10.1007/s00774-020-01159-1. View

Kastrati K, Aletaha D, Burmester G, Chwala E, Dejaco C, Dougados M . A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases. RMD Open. 2022; 8(2). PMC: 9462104. DOI: 10.1136/rmdopen-2022-002359. View

Lin Q, Zhou C, Bai M, Zhu D, Chen J, Wang H . Exosome-mediated miRNA delivery promotes liver cancer EMT and metastasis. Am J Transl Res. 2020; 12(3):1080-1095. PMC: 7137059. View

Wang L, Wang C, Jia X, Yu J . Circulating Exosomal miR-17 Inhibits the Induction of Regulatory T Cells via Suppressing TGFBR II Expression in Rheumatoid Arthritis. Cell Physiol Biochem. 2018; 50(5):1754-1763. DOI: 10.1159/000494793. View

Liao W, Fu Z, Zou Y, Wen D, Ma H, Zhou F . MicroRNA-140-5p attenuated oxidative stress in Cisplatin induced acute kidney injury by activating Nrf2/ARE pathway through a Keap1-independent mechanism. Exp Cell Res. 2017; 360(2):292-302. DOI: 10.1016/j.yexcr.2017.09.019. View

Hu Y, Wang Y, Chen T, Hao Z, Cai L, Li J . Exosome: Function and Application in Inflammatory Bone Diseases. Oxid Med Cell Longev. 2021; 2021:6324912. PMC: 8423581. DOI: 10.1155/2021/6324912. View

Skryabin G, Komelkov A, Savelyeva E, Tchevkina E . Lipid Rafts in Exosome Biogenesis. Biochemistry (Mosc). 2020; 85(2):177-191. DOI: 10.1134/S0006297920020054. View

Narazaki M, Tanaka T, Kishimoto T . The role and therapeutic targeting of IL-6 in rheumatoid arthritis. Expert Rev Clin Immunol. 2017; 13(6):535-551. DOI: 10.1080/1744666X.2017.1295850. View

Mori M, Ludwig R, Garcia-Martin R, Brandao B, Kahn C . Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease. Cell Metab. 2019; 30(4):656-673. PMC: 6774861. DOI: 10.1016/j.cmet.2019.07.011. View

10.

Kameda H, Nishida K, Nanki T, Watanabe A, Oshima Y, Momohara S . Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study. Mod Rheumatol. 2022; 33(3):460-471. DOI: 10.1093/mr/roac073. View

11.

Zhang B, Gu J, Wang Y, Guo L, Xie J, Yang M . TNF-α stimulated exosome derived from fibroblast-like synoviocytes isolated from rheumatoid arthritis patients promotes HUVEC migration, invasion and angiogenesis by targeting the miR-200a-3p/KLF6/VEGFA axis. Autoimmunity. 2023; 56(1):2282939. DOI: 10.1080/08916934.2023.2282939. View

12.

Hariharan H, Kesavan Y, Raja N . Impact of native and external factors on exosome release: understanding reactive exosome secretion and its biogenesis. Mol Biol Rep. 2021; 48(11):7559-7573. DOI: 10.1007/s11033-021-06733-y. View

13.

Meldolesi J . Exosomes and Ectosomes in Intercellular Communication. Curr Biol. 2018; 28(8):R435-R444. DOI: 10.1016/j.cub.2018.01.059. View

14.

Montepaone M, Lubrano E, Carboni A, Spadaro A . Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis. Open Access Rheumatol. 2014; 6:7-13. PMC: 5045109. DOI: 10.2147/OARRR.S56048. View

15.

Mollard E, Michaud K . Mobile Apps for Rheumatoid Arthritis: Opportunities and Challenges. Rheum Dis Clin North Am. 2019; 45(2):197-209. DOI: 10.1016/j.rdc.2019.01.011. View

16.

Jiang Q, Yang G, Liu Q, Wang S, Cui D . Function and Role of Regulatory T Cells in Rheumatoid Arthritis. Front Immunol. 2021; 12:626193. PMC: 8047316. DOI: 10.3389/fimmu.2021.626193. View

17.

Zheng J, Zhu L, In I, Chen Y, Jia N, Zhu W . RETRACTED: Bone marrow-derived mesenchymal stem cells-secreted exosomal microRNA-192-5p delays inflammatory response in rheumatoid arthritis. Int Immunopharmacol. 2019; 78:105985. DOI: 10.1016/j.intimp.2019.105985. View

18.

Takeuchi Y, Hirota K, Sakaguchi S . Impaired T cell receptor signaling and development of T cell-mediated autoimmune arthritis. Immunol Rev. 2020; 294(1):164-176. DOI: 10.1111/imr.12841. View

19.

Ruscitti P, Cipriani P, Liakouli V, Carubbi F, Berardicurti O, Di Benedetto P . The Emerging Role of IL-1 Inhibition in Patients Affected by Rheumatoid Arthritis and Diabetes. Rev Recent Clin Trials. 2018; 13(3):210-214. DOI: 10.2174/1574887113666180314102651. View

20.

Jafari D, Malih S, Eini M, Jafari R, Gholipourmalekabadi M, Sadeghizadeh M . Improvement, scaling-up, and downstream analysis of exosome production. Crit Rev Biotechnol. 2020; 40(8):1098-1112. DOI: 10.1080/07388551.2020.1805406. View